Tony Cataldo serves as Executive at Genesis Biopharma, Inc, where they oversee executive responsibilities. Since joining the company, Tony Cataldo has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 2, 2020 involved selling 4,234,320 shares valued at $0.
Tony Cataldo currently holds 6,500,000 shares of Genesis Biopharma, Inc (GNBP.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tony Cataldo has been a net neutral trader of GNBP.OB stock. They have purchased $0 and sold $0 worth of shares.
Tony Cataldo's most recent insider trade was on Jun 2, 2020, when they sold 4,234,320 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 6, 2019 | GTBP | $0 | Sale | 800,000 | $N/A | Discretionary |
| Nov 2, 2017 | GTBP | $0 | Gift | 100,000 | $N/A | Discretionary |
| Nov 2, 2017 | GTBP | $0 | Gift | 3,000,000 | $N/A | Discretionary |
| Nov 2, 2017 | GTBP | $0 | Gift | 200,000 | $N/A | Discretionary |
| Sep 1, 2017 | GTBP | $0 | Award | 5,129,660 | $N/A | Discretionary |
| May 6, 2011 | GNBP.OB | $3.7M | Award | 3,000,000 | $1.23 | Discretionary |